FONR: FONAR Corporation Stock

by  •  • Comments Off on FONR: FONAR Corporation Stock

SIC 3845 – Electromedical and Electrotherapeutic Apparatus

Valuation
Market Cap ($M) 77.48
Enterprise Value ($M) 13.07
Book Value ($M) 158.95
Book Value / Share 25.62
Price / Book 0.49
NCAV ($M) 88.63
NCAV / Share 14.29
Price / NCAV 0.87

Profitability (mra)
Return on Invested Capital (ROIC) 0.04
Return on Assets (ROA) 0.04
Return on Equity (ROE) 0.05

Liquidity (mrq)
Quick Ratio 11.01
Current Ratio 11.24

Balance Sheet (mrq) ($M)
Current Assets 137.63
Assets 207.96
Liabilities 49.01
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-14 13G Money Concepts Capital Corp 6.00
11-13 13G Renaissance Technologies Llc 5.27 10.02

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-19 10-Q FORM 10-Q SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended DECEMBER 31, 2024 Commission file number 0-10248 FONAR CORPORATION
2024-11-12 10-Q FORM 10-Q SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended SEPTEMBER 30, 2024 Commission file number 0-10248 FONAR CORPORATION
2024-09-27 10-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF
2024-05-15 10-Q FORM 10-Q SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended MARCH 31, 2024 Commission file number 0-10248 FONAR CORPORATION (Ex

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-30 767 14,250 5.38
2025-04-29 954 10,751 8.87
2025-04-28 2,409 19,104 12.61

(click for more detail)

Similar Companies
ECOR – electroCore, Inc. ESTA – Establishment Labs Holdings Inc.
FEMY – Femasys Inc. GCTK – GlucoTrack, Inc.
HSCS – HeartSciences Inc.


Financial data and stock pages provided by
Fintel.io